CN Patent
CN105163748B — 用于肥胖症的功能性多肽
Assigned to Danone SA Spain · Expires 2017-11-21 · 8y expired
What this patent protects
本发明涉及特定多肽,其可通过属于乳杆菌属或链球菌属的菌株的培养上清液作用自大豆球蛋白水解而获得。这些多肽、含有其的提取物和含有其的食品产品可用于治疗和/或预防肥胖和氧化应激。
USPTO Abstract
本发明涉及特定多肽,其可通过属于乳杆菌属或链球菌属的菌株的培养上清液作用自大豆球蛋白水解而获得。这些多肽、含有其的提取物和含有其的食品产品可用于治疗和/或预防肥胖和氧化应激。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.